HIV-assosiated lymphoma: a case report
AbstractMalignancies develop in 25 to 40% of people living with HIV (PLWH) and become the leading cause of morbidity and mortality in PLWH. Among HIV-associated malignancies more than 40% of HIV-positive people are eventually diagnosed with AIDS-associated lymphomas. Timely diagnosis and initiation of the specific therapy in patients with HIV-infection present significant difficulties due to the lack of specific lymphoma symptoms and possible comorbid infection with secondary infectious agents. A case report of HIV-associated lymphoma is present.
Keywords:HIV-infection; AIDS; lymphoma; HIV-related lymphoma
Funding. There is no funding to report.
Conflict of interest. All authors declared that there are no competing interests in this work.
Contribution. Observation of the patient, article design, article editing – Gadzhikulieva M.M., Chernysheva O.O.; observation of the patient and treatment of the patient, article design – Tsvetkova O.O.; pathomorphological research, article design – Tishkevich O.A.
For citation: Gadzhikulieva M.M., Tsvetkova O.O., Chernysheva O.O., Tishkevich O.A. HIV-assosiated lymphoma: a case report. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2023; 12 (2): 120–6. DOI: https://doi.org/10.33029/2305-3496-2023-12-2-120-126 (in Russian)
References
1. UNAIDS. 2022 Global AIDS Update: In Danger. In: 2022 Global AIDS Update. 2022: 376 p.
2. Berhan A., Bayleyegn B., Getaneh Z. HIV/AIDS associated lymphoma: Review. Blood Lymphat Cancer. 2022; 12 (3): 1–45. DOI: https://doi.org/10.2147/BLCTT.S361320
3. Yarchoan R., Uldrick T.S. HIV-associated cancers and related diseases. N Engl J Med. 2018; 378 (11): 1029–41. DOI: https://doi.org/10.1056/NEJMra1615896
4. Re A., Cattaneo C., Rossi G. HIV and lymphoma: From epidemiology to clinical management. Mediterr J Hematol Infect Dis. 2019; 11 (1): 1–17. DOI: https://doi.org/10.4084/MJHID.2019.004
5. Pongas G.N., Ramos J.C. HIV-associated lymphomas: Progress and new challenges. J Clin Med. 2022; 11 (5): 14–47. DOI: https://doi.org/10.3390/jcm11051447
6. Riedel D.J., et al. HIV-associated lymphoma sub-type distribution , immunophenotypes and survival in an urban clinic population. Leuk Lymphoma. 2015; 57 (2): 1–7. DOI: https://doi.org/10.3109/10428194.2015.1055483
7. Baptista M.J., et al. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era. AIDS. 2015; 29 (7): 811–8. DOI: https://doi.org/10.1097/QAD.0000000000000624
8. de Carvalho P.S., Leal F.E., Soares M.A. Clinical and molecular properties of human immunodeficiency virus-related diffuse large B-cell lymphoma. Front Oncol. 2021; 11: 653–75. DOI: https://doi.org/10.3389/fonc.2021.675353
9. Wang C., Liu J., Liu Y. Progress in the treatment of HIV-associated lymphoma when combined with the antiretroviral therapies. Front Oncol. 2022; 11: 798–808. DOI: https://doi.org/10.3389/fonc.2021.798008
10. Hentrich M., et al. Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). Ann Hematol. 2014; 93 (6): 913–21. DOI: https://doi.org/10.1007/s00277-014-2058-4
11. Hevroni G., et al. HIV-associated Hodgkin Lymphoma with a granulomatous bone marrow biopsy: A case report. Am J Med Case Rep. 2021; 9 (1): 83–7. DOI: https://doi.org/10.12691/ajmcr-9-1-21
12. Connors J.M., et al. Hodgkin lymphoma. Nat Rev Dis Prim. 2020; 6 (1): 61–86. DOI: https://doi.org/10.1038/s41572-020-0189-6
13. Chen J., et al. A novel prognostic score including the CD4/CD8 for AIDS-related lymphoma. Front Cell Infect Microbiol. 2022; 12: 1–10. DOI: https://doi.org/10.3389/fcimb.2022.919446